Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

XHEvsGNOMETF Comparison

ETF 1
XHE

State Street SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
+0.32%
VS
ETF 2
GNOM

Global X Genomics & Biotechnology ETF

This fund is part of
BioTech & Genomics
-2.11%

State Street SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. Global X Genomics & Biotechnology ETF (GNOM) is part of the BioTech & Genomics segment. XHE's top 3 sector exposures are Healthcare and Finance. In contrast, GNOM's top sector exposures are Healthcare and Industrials. XHE is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.5% for GNOM. XHE is down -3.04% year-to-date (YTD) with +$2M in YTD flows. GNOM performs better with 18.8% YTD performance, and +$18M in YTD flows. Run a side-by-side ETF comparison of XHE and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHE vs GNOM performance and flow charts

Performance

0246810%Jun 24Jul 1Jul 9Jul 16Jul 23

Cumulative Flows

0 M5 M10 M15 M20 MJun 24Jul 1Jul 9Jul 16Jul 23

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/24/2026
1M3MYTD1Y3Y5Y
Perf.
XHE
GNOM
+3.29%+0.87%
+3.26%+17.93%
-3.04%+18.80%
+8.72%+51.85%
-12.17%+12.37%
-31.68%-38.62%
Flows
XHE
GNOM
+$2M+$14M
+$26M+$19M
+$2M+$18M
-$18M+$13M
-$379M-$95M
-$397M-$862K
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHE
GNOM
+26.19%+28.84%
+22.63%+26.67%
+22.18%+29.09%
+24.70%+33.32%
Max drawdown
XHE
GNOM
-6.40%-8.57%
-18.20%-18.16%
-32.21%-43.23%
-49.90%-72.01%
Max drawdown duration
XHE
GNOM
43d18d
197d145d
1094d905d
1786d1786d
Trading data

Create an account to view trading data

Join for free
XHE
GNOM
Last sale
7/27/2026 at 1:30 PM
$87.54
$53.69
Previous close
07/24/2026
$85.18
$53.99
Consolidated volume
07/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHE
GNOM
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/27/2026 at 1:30 PM
Live
Closed
XHE
GNOM
Last price
$87.54
$53.69
1D performance
+2.77%
-0.55%
AuM$151.67 M$79.16 M
E/R0.35%0.5%
Characteristics
XHE
GNOM
Management strategyPassivePassive
ProviderState Street Investment ManagementGlobal X
BenchmarkS&P Health Care Equipment Select Industry IndexSolactive Genomics Index
N° of holdings6750
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2011April 5, 2019
ESGNoNo
Advertisement
Exposure

Countries

XHE
USA
89.54%
Other
10.46%
GNOM
USA
84.1%
Other
15.9%

Sectors

XHE
Healthcare
94.54%
Other
5.46%
GNOM
Healthcare
99.75%
Other
0.25%
Advertisement

Diversification

XHE

Total weight of top 15 holdings out of 15

26.73%
GNOM

Total weight of top 15 holdings out of 15

61.22%

Top 15 holdings

Data as of June 30, 2026
XHE
Butterfly Network, Inc.
2.45%
QuidelOrtho Corp.
2.04%
Glaukos Corp.
1.79%
UFP Technologies, Inc.
1.79%
Axogen, Inc.
1.76%
Lantheus Holdings, Inc.
1.74%
Artivion, Inc.
1.73%
Envista Holdings Corp.
1.72%
Omnicell, Inc.
1.71%
Medline, Inc.
1.69%
Alphatec Holdings, Inc.
1.67%
Dentsply Sirona, Inc.
1.66%
Inspire Medical Systems, Inc.
1.66%
The Cooper Cos., Inc.
1.66%
Edwards Lifesciences Corp.
1.65%
GNOM
Guardant Health, Inc.
5.78%
Twist Bioscience Corp.
5.09%
Illumina, Inc.
4.67%
Natera, Inc.
4.41%
Moderna, Inc.
4.22%
Veracyte, Inc.
4.12%
Bio-Techne Corp.
4.08%
Vertex Pharmaceuticals, Inc.
3.85%
Legend Biotech Corp.
3.82%
10X Genomics, Inc.
3.70%
Arrowhead Pharmaceuticals, Inc.
3.67%
BioMarin Pharmaceutical, Inc.
3.59%
Praxis Precision Medicines, Inc.
3.50%
CRISPR Therapeutics AG
3.36%
QIAGEN NV
3.35%
Frequently asked questions about XHE and GNOM

How have the XHE and GNOM ETFs performed in 2026?

As of July 24, 2026, XHE is down -3.04% year-to-date (YTD), while GNOM has returned 18.8%. That puts GNOM better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or GNOM?

Year-to-date, the XHE ETF saw +$2M in flows, compared to +$18M for GNOM.

Which ETF is more volatile: XHE or GNOM?

Over the past year, XHE had a volatility of 22.63%, while GNOM experienced 26.67%.

Which ETF is bigger: XHE or GNOM?

As of July 24, 2026, XHE holds $151.67 M in assets under management (AUM), while GNOM manages $79.16 M.

What sectors do the XHE and GNOM ETFs invest in?

XHE leans toward sectors like Healthcare. Meanwhile, GNOM focuses on Healthcare.

What are the top holdings of the XHE ETF and GNOM ETF?

XHE top holdings include Butterfly Network, Inc., QuidelOrtho Corp. and Glaukos Corp.. GNOM holds in its top three: Guardant Health, Inc., Twist Bioscience Corp. and Illumina, Inc..

Which ETF is more diversified: XHE or GNOM?

XHE holds 67 securities with 26.73% of its assets in the top 15. GNOM has 50 securities and a top 15 weight of 61.22%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder